A case-control study of NAFLD patients highlighted a potentially protective role for the Val227Ala variant of PPARα against obesity compared to subjects with the wild-type receptor (Chen et al., 2008a). Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.